2012 Signal Transduction By Engineered Extracellular Matrices Gordon Research Con
2012 Signal Transduction By Engineered Extracellular Matrices Gordon Research Con
批准号:
8387261
负责人:
Karen Kemper Hirschi
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-07 至 2013-06-30
关键词:
AddressAreaBiocompatible MaterialsBiologyBiomedical EngineeringBiotechnologyCell AdhesionCell membraneCell physiologyCellsCellular biologyChemistryChronicClinicalCollaborationsCommitCommunicationCommunitiesCuesDNADevelopmentDevelopmental BiologyDiagnosisDimensionsDiseaseEconomicsEngineeringEnsureEnvironmentExtracellular MatrixFosteringFundingFutureGoalsGovernmentGrowthHereditary DiseaseHumanImageInjuryInstitutionInterventionKnowledgeLinkMalignant neoplasm of lungMarketingMedicineMinorityMissionModelingMolecular and Cellular BiologyNational Heart, Lung, and Blood InstituteNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Biomedical Imaging and BioengineeringNational Institute of Dental and Craniofacial ResearchNew EnglandOralOrganismParticipantPharmacotherapyPhysiologyPostdoctoral FellowPublic HealthRegenerative MedicineResearchResearch PersonnelRestRunningScienceSignal TransductionStem cellsStressStudentsThinkingTimeTissue EngineeringTissuesTranslationsTravelUnited States National Institutes of HealthUniversitiesWomanWorkWound Healingbeneficiarybioimagingburden of illnesscareercell growth regulationcellular engineeringchemotherapydesignelectric fieldexperiencein vivoinnovationinsightinterestmeetingsmultidisciplinaryplanetary Atmosphereposterspostnatalpre-doctoralrelating to nervous systemrepairedstem cell biologysymposiumtissue regenerationtissue repairvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Gordon Research Conference (GRC) on Signal Transduction By Engineered Extracellular Matrices was established in 2000 and has become the premier meeting at the intersection of engineered materials, cellular adhesion and signaling, tissue engineering, and stem cell biology. The 2012 meeting, to be held July 8-13, 2012, at the University of New England in Biddeford, ME, adds another important dimension - linking stem cell/engineered matrix constructs to developmental models and human clinical therapy. The meeting Chair will be Dr. Karen Hirschi and the Vice-Chair will be Dr. Jason Burdick. These investigators provide complimentary expertise in these emerging fields. The main objective of the conference will be to share the newest knowledge from research on: the establishment and regulation of the cellular microenvironment during development and in postnatal tissues; how the cellular microenvironment can be engineered to control cell function; how the fate of cells can be dynamically tracked in vivo; and how such insights can be applied to the development and optimization of human clinical therapies for tissue repair and regeneration. Thus, this meeting necessarily brings together researchers in diverse fields of biology (including stem cell and developmental biology), chemistry, bioimaging and engineering for both the understanding of cellular function and how this can be harnessed for the repair and replacement of tissues lost or damaged due to disease or injury, which serves to encourage cross-disciplinary thinking. Speakers will include well-established leaders in the field as well as young investigators of exceptional promise. In addition to the plenary talks, the meeting includes lively and highly interactive poster sessions. Importantly, 3 poster presenters will be invited to give short oral presentations in every morning session, for a total of 12 oral poster presenters. The main conference will also be preceded by a weekend meeting planned by and for pre-doctoral and post-doctoral trainees in this growing interdisciplinary field. This pre-meeting, the Gordon - Kenan Graduate Research Seminar, will provide a forum for these future leaders in the field to present their work in talks and posters, in a collegial and interactive environment that will add outstanding value to their overall GRC experience. Overall, the meeting will provide a platform for the development of long term interdisciplinary interactions, and expose students and young professionals to the latest ideas and opportunities at the confluence of signal transduction, molecular and cellular biology, biomaterials and tissue engineering. PUBLIC HEALTH RELEVANCE: The Conference, ongoing for the past 30 years, focuses on the interactions of membranes, cells, and organisms with electric fields, with a special interest in those involved in diagnosis and treatment of disease, including cancer, pulmonary, neural, genetic disorders, and chronic wounds. In high voltage fields, cell permeabilization can occur which can be used to load cells with chemotherapy or DNA, whereas in weak electric fields, cells may respond to directional cues and this can be used in wound healing. By emphasizing basic mechanisms revealed by multidisciplinary studies involving engineering, chemistry, materials science, imaging, cell biology, physiology, and medicine, in an atmosphere fostering the free and open exchange of ideas, the Conference hopes to accelerate optimal design of drug therapies and other interventions to ease the burden these disease states place on the nation's public health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2022 Endothelial Cell Phenotypes GRC and GRS
-
批准号:10464521
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Karen Kemper Hirschi
-
依托单位:
miR-223 regulates endothelial to hematopoietic transition
-
批准号:10763971
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2020
-
负责人:Karen Kemper Hirschi
-
依托单位:
miR-223 regulates endothelial to hematopoietic transition
-
批准号:10557218
-
项目类别:
-
资助金额:$69.23万
-
财政年份:2020
-
负责人:Karen Kemper Hirschi
-
依托单位:
miR-223 regulates endothelial to hematopoietic transition
-
批准号:10348182
-
项目类别:
-
资助金额:$69.23万
-
财政年份:2020
-
负责人:Karen Kemper Hirschi
-
依托单位:
Endothelial Cell Cycle State and Cell Fate
-
批准号:10454316
-
项目类别:
-
资助金额:$52.12万
-
财政年份:2019
-
负责人:Karen Kemper Hirschi
-
依托单位:
Endothelial Cell Cycle State and Cell Fate
-
批准号:10208947
-
项目类别:
-
资助金额:$52.61万
-
财政年份:2019
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neurovascualar Regeneration
-
批准号:8632715
-
项目类别:
-
资助金额:$103.88万
-
财政年份:2014
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neurovascualar Regeneration
-
批准号:8791687
-
项目类别:
-
资助金额:$93.86万
-
财政年份:2014
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neurovascualar Regeneration
-
批准号:9002043
-
项目类别:
-
资助金额:$94.23万
-
财政年份:2014
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neurovascualar Regeneration
-
批准号:9144260
-
项目类别:
-
资助金额:$11.6万
-
财政年份:2014
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neurovascualar Regeneration
-
批准号:9199415
-
项目类别:
-
资助金额:$92.18万
-
财政年份:2014
-
负责人:Karen Kemper Hirschi
-
依托单位:
Human Endothelial Cell Differentiation
-
批准号:8248240
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2009
-
负责人:Karen Kemper Hirschi
-
依托单位:
Human Endothelial Cell Differentiation
-
批准号:7675918
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2009
-
负责人:Karen Kemper Hirschi
-
依托单位:
Human Endothelial Cell Differentiation
-
批准号:7789529
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2009
-
负责人:Karen Kemper Hirschi
-
依托单位:
Human Endothelial Cell Differentiation
-
批准号:8386739
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2009
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neuro-Vascular Regeneration
-
批准号:7847396
-
项目类别:
-
资助金额:$118.25万
-
财政年份:2006
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neuro-Vascular Regeneration
-
批准号:7209285
-
项目类别:
-
资助金额:$99.72万
-
财政年份:2006
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neuro-Vascular Regeneration
-
批准号:7495614
-
项目类别:
-
资助金额:$106.85万
-
财政年份:2006
-
负责人:Karen Kemper Hirschi
-
依托单位:
Neuro-Vascular Regeneration
-
批准号:7291042
-
项目类别:
-
资助金额:$111.71万
-
财政年份:2006
-
负责人:Karen Kemper Hirschi
-
依托单位:
Tissue Engineering of Hematopoietic Bone
-
批准号:7880481
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2005
-
负责人:Karen Kemper Hirschi
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: